Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/1999
10/19/1999US5968501 Genetically engineering, transformation
10/19/1999CA2197298C Novel pyrimidine derivatives and processes for the preparation thereof
10/17/1999CA2269262A1 Substituted tricyclics
10/16/1999CA2269049A1 N-acyl and n-aroyl aralkyl amides
10/14/1999WO1999051608A1 THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
10/14/1999WO1999051605A1 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR
10/14/1999WO1999051600A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES
10/14/1999WO1999051599A1 Aminoalkyl substituted pyrrolo[2,3-b]pyridine and pyrrolo[2,3-d]pyrimidine derivatives: modulators of crf1 receptors
10/14/1999WO1999051597A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
10/14/1999WO1999051596A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051595A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051571A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999WO1999051564A1 Propanolamine derivatives
10/14/1999WO1999051559A1 Anti-inflammatory, antibacterial benzyl phenol agents
10/14/1999WO1999051241A1 Calcilytic compounds and method of use
10/14/1999WO1999051234A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051233A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051232A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051203A1 Maximizing effectiveness of substances used to improve health and well being
10/14/1999WO1999043361A8 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
10/14/1999WO1999037604A3 Dialkyl ureas as calcitonin mimetics
10/14/1999CA2327188A1 Calcilytic compounds and method of use
10/14/1999CA2327113A1 Anti-inflammatory, antibacterial benzyl phenol agents
10/14/1999CA2327068A1 Maximizing effectiveness of substances used to improve health and well being
10/14/1999CA2326884A1 Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists
10/14/1999CA2326759A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
10/14/1999CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b|indole and 9h-pyrimidino¬4,5-b|indole derivatives:crf1 and npy1 receptors
10/14/1999CA2326522A1 Pyrrolo¬1,2-a|pyrazine spla2 inhibitor
10/14/1999CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b|pyridine and pyrrolo¬2,3-d|pyrimidine derivatives: modulators of crf1 receptors
10/14/1999CA2326319A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino¬2,3-b|indole and 5,6,7,8-tetrahydro-9h-pyrimidino¬4,5-b|indole derivatives: crf1 specific ligands
10/14/1999CA2326185A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326184A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326143A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326140A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326139A1 Antagonists of gonadotropin releasing hormone
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948544A1 Monovalent antibody fragments
10/13/1999EP0948535A1 Novel lanthionine antibiotic compositions and methods
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948500A1 Cyclic organoselenium compounds, their preparation and their uses
10/13/1999EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999EP0936912A4 Inhibitors of cysteine protease
10/13/1999CN1231666A Tricyclic benzazepine vasopressin antagonists
10/13/1999CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin
10/13/1999CN1231601A Oral delayed immediate release formulation and method of preparation therefor
10/13/1999CN1231202A Traditional Chinese medicine preparation for treating colitis
10/13/1999CN1045602C Tetrahydropyrido-indole derivant and medicinal composition and pharmaceutical use thereof
10/13/1999CN1045601C Novel quinuclidine derivatives and medicinal composition thereof
10/12/1999US5965701 Kappa receptor opioid peptides
10/12/1999US5965693 Isolated polynucleotides; diagnosis and treatment of autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disorder, viricides, bactericides, fungicides and anticarcinogenic agents
10/12/1999US5965586 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
10/12/1999US5965585 Suppressing formation of collagen and collagen-like substances or biosynthesis of procollagen in living systems by administering a hydroxypyridone compound enzyme inhibitor of protein hydroxylase; antiscarring agents
10/12/1999US5965583 Substituted imidazoles useful in the treatment of inflammatory disease
10/12/1999US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999US5965579 Antagonists of the neurotensin receptors; increasing affinity for human neurotensin receptors
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965562 Treating disorders induced by substance p and migraine headache
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965403 Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
10/12/1999US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999US5965127 Exocellular polysaccharide produced by streptococcus thermophilus
10/07/1999WO1999050413A2 THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY
10/07/1999WO1999050237A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
10/07/1999WO1999050230A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
10/07/1999WO1999049888A2 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
10/07/1999WO1999049875A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients
10/07/1999WO1999043310A3 20-hete antagonists and agonists
10/07/1999WO1999038888A3 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
10/07/1999WO1999030720A9 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/07/1999CA2326391A1 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
10/07/1999CA2325997A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
10/07/1999CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
10/07/1999CA2291780A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946587A2 New amide compounds
10/06/1999EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS
10/06/1999EP0946557A1 A-1-adenosine receptor antagonists
10/06/1999EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/06/1999EP0946547A1 A novel compound form
10/06/1999EP0946541A1 Quinolines and their therapeutic use
10/06/1999EP0946523A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
10/06/1999EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity
10/06/1999EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999EP0946510A1 Novel compounds with analgesic effect
10/06/1999EP0946501A1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
10/06/1999EP0946176A1 The use of 7-(2-oxa-5,8-diazabicyclo 4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of helicobacter pylori infections and associated gastroduodenal diseases
10/06/1999EP0946155A1 Pharmaceutical composition for treating fecal incontinence and anal itch
10/06/1999CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation
10/06/1999CN1230891A Lectin compositions and uses thereof
10/06/1999CN1230421A Chinese medicine preparation for curing residual jaundice of viral hepatitis
10/05/1999US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999US5962529 Metalloproteinase inhibitors
10/05/1999US5962503 Use of cholinesterase inhibitors in the treatment of xerostomia
10/05/1999US5962502 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
10/05/1999US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
1 ... 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 ... 1258